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Background: Timing of childhood vaccinations has received close attention in many countries. Little is known
about the trends in correctly timed vaccination in former Soviet countries. We examined trends in vaccination
coverage and correct timing of vaccination in two post-Soviet countries, Armenia and Kyrgyzstan, and analyzed
factors associated with delayed vaccinations.
Methods: We used data from the Demographic and Health Surveys; the surveys were conducted in 2000
(n = 1726), 2005 (n = 1430) and 2010 (n = 1473) in Armenia and in 1997 (n = 1127) and 2012 (n = 4363) in
Kyrgyzstan. We applied the Kaplan-Meier method to estimate age-specific vaccination coverage with diphtheria,
tetanus and pertussis (DTP) vaccine and a measles-containing vaccine (MCV). A Cox proportional hazard regression
with shared frailty was used to examine factors associated with delayed vaccinations.
Results: Vaccination coverage for all three doses of the DTP vaccine increased in Armenia from 92 % in 2000
to 96 % in 2010. In Kyrgyzstan, DTP coverage was 96 % and 97 % in 1997 and 2012, respectively. Vaccination
coverage for MCV increased from 89 % (Armenia, 2000) and 93 % (Kyrgyzstan, 1997) to 97 % (Armenia, 2010)
and 98 % (Kyrgyzstan, 2012). The proportion of children with correctly timed vaccinations increased over time
for all examined vaccinations in both countries. For example, the proportion of children in Armenia with
correctly timed first DTP dose (DTP1) increased from 46 % (2000) to 66 % (2010). In Kyrgyzstan, the proportion of
correctly timed DTP1 increased from 75 % (1997) to 87 % (2012). In Armenia, delays in the third DTP dose (DTP3) and
MCV vaccinations were less likely to occur in the capital, whereas in Kyrgyzstan DTP3 and MCV start was delayed in the
capital compared to other regions of the country. Also, in Armenia living in urban areas was associated with delayed
vaccinations.
Conclusions: Vaccination coverage and timing of vaccination improved over the last years in both countries. Further
efforts are needed to reduce regional differences in timely vaccinations.
Keywords: Vaccination coverage, Timing of vaccination, Demographic and Health Survey, Post-Soviet countries,
Armenia, KyrgyzstanBackground
Achieving high vaccination coverage is a necessary, but
an insufficient indicator of the quality of vaccination
programs geared towards preventing childhood infec-
tious diseases. The timing of vaccination is increasingly
recognized as another important target for optimal pro-
tection of children [1] and has received close attention* Correspondence: aparna.schweitzer@dzne.de
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measure of vaccination coverage and also compliance
with recommended vaccinations is usually estimated
based on the percentage of children in a specific age
group who have received the recommended number of
vaccine doses without regard to the timing of vaccin-
ation [4, 5]. Studies have demonstrated that high vaccin-
ation coverage rates do not necessarily imply correctly
timed vaccinations [3, 6–9]. According to Clark et al.,
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national coverage do not capture these variations [3]. In-
correctly timed (early or delayed) vaccination doses
might in fact explain the persistence or even the resur-
gence of vaccine-preventable infections, which is espe-
cially relevant for countries where high levels of
vaccination coverage at milestone ages have been
achieved [10, 11]. Outbreaks of diseases such as measles
can occur in a population with high vaccination cover-
age [12]. This has been attributed to vaccine failure
resulting from individuals being vaccinated outside the
recommended period [13].
The timely start of vaccination is important in light of
the rapid waning of transplacental immunity in the first
year of life against vaccine-preventable diseases such as
pertussis and invasive Haemophilus influenzae type b
disease [8]. Delayed doses in turn put individuals at risk
of disease due to waning immunity over time and put
the whole community at risk of epidemics [14]. Thus, it
is important to take the correct timing of vaccination
into account, as relying exclusively on vaccination cover-
age alone can lead to a false assumption of disease pro-
tection [6, 10].
In a previous analysis of childhood vaccination in sev-
eral post-Soviet countries, we observed that a substantial
proportion of children was vaccinated with delays
[2, 15]. Little is known about the trends in vaccination
coverage and correctly timed vaccination over time in
these countries. This is especially important since health
care systems in these countries underwent a deep transi-
tion. After the collapse of the Soviet Union, the health
care systems of the Newly Independent States (NIS)
moved from the Semashko model, a centralized health-
care system, to a range of institutional, financial arrange-
ments and out-of-pocket payments [16]. These factors,
in turn, may contribute to a decrease in health-care
utilization, particularly among the poor, which, together
with the level of poverty and decaying socio-economic
health infrastructure, alter the morbidity profile [16].
These changes were reflected in sharp drops in vaccin-
ation coverage in the early 1990s in the Central Asian
and Caucasian republics [17, 18]. Increased outbreaks of
some vaccine-preventable diseases, such as diphtheria
and measles, were observed in the mid 1990s although
vaccination coverage increased to up to 90 % in the NIS
after 1995 [17, 19], which could be accounted for by de-
layed vaccinations.
In the current analysis we used data from two post-
Soviet countries (Armenia and Kyrgyzstan) that allow
tracing changes in vaccination coverage and timing of
vaccination over time. Both countries have adopted the
WHO guidelines for childhood vaccinations [20, 21].
These guidelines call for all children to receive the fol-
lowing: a BCG vaccine against tuberculosis; three dosesof the diphtheria, pertussis, and tetanus (DPT) vaccine,
three doses of polio vaccine, and a measles vaccine dur-
ing the first year of life [22]. Specifically, we aimed to
estimate the trends in vaccination coverage and correctly
timed vaccination for selected childhood vaccinations
over time and to analyze factors associated with delayed
vaccinations.
Methods
We used data from the Demographic and Health Surveys
(DHS) in two countries, Armenia and Kyrgyzstan, where
multiple surveys over a period of several years were avail-
able. The surveys were conducted in 2000, 2005 and 2010
in Armenia and in 1997 and 2012 in Kyrgyzstan. DHS are
nationally representative household surveys that provide
data for a wide range of monitoring and impact evaluation
indicators in the areas of population, health, and nutrition
[14]. These surveys provide the most recent information
about vaccination coverage in some post-Soviet countries
and are independent of the official health reports, which
are known to overestimate vaccination coverage [18].
A multi-stage sampling technique was used in the
DHS surveys to obtain representative samples in both
countries. In the first stage, sampling areas were selected
separately in urban and rural areas. In rural areas a vil-
lage was the sampling unit. Urban areas are subdivided
into “health blocks”, i.e. districts for which doctors from
local clinics are responsible. A list of all households was
obtained from the respective authorities. In the second
stage, households with women of reproductive age be-
tween 15 and 49 years were randomly selected. Informa-
tion about reproductive health of women, infant and
child mortality, nutrition of women and children, and
vaccination data were collected in the surveys using
standard DHS questionnaires [14].
Vaccination data were obtained mostly from child
health cards available at local health care facilities or by
information recalled by the mother in the event that
the mother did not have a child health card or an
immunization was not recorded on the card. We used
data on three doses of diphtheria, tetanus and pertussis
(i.e. DTP1, DTP2 and DTP3) vaccine and the first dose
of a measles-containing vaccine (MCV). The Polio vac-
cine was omitted from the analysis because it is given
according to the same schedule as DTP; consequently,
the timing of administration is expected to be the same
for both, and most children either received both or
neither.
We assessed vaccination coverage and timing of vac-
cination in accordance with the respective national
immunization schedules of Armenia and Kyrgyzstan.
We defined vaccinations as correctly timed if adminis-
tered within 4 weeks after the recommended age speci-
fied in the national immunization schedule (Table 1).
Table 1 Recommended age for DTP and MCV vaccinations for
children in Armenia and Kyrgyzstan as per the WHO guidelines
for childhood vaccinations
Vaccines
Country DTP1 DTP2 DTP3 MCV
Armenia 3 months 4.5 months 6 months 12 months
Kyrgyzstan 2 months 3.5 months 5 months 12 months
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the proportion of children vaccinated between 12 and
59 months of age for DTP vaccines and between 18 and
59 months of age for MCV.
Statistical analysis
Initially, we assessed UTD vaccination coverage using
data procured from health cards and/or recalled by the
parents. This analysis included a sample of children be-
tween 12 and 59 months of age for DTP vaccines and
between 18 and 59 months for MCV. Furthermore, we
applied the Kaplan–Meier method to estimate vaccin-
ation coverage at any given age. For this analysis we did
not restrict the sample, i.e. all children between 0 and
59 months were included. Data from all children for
whom complete information on birthdate and dates of
vaccination were available were used for this analysis. If
vaccination had not been received by the day of inter-
view, the case was considered as censored. The survival
function S(age), i.e. the proportion of children not vacci-
nated at the end of an age interval divided by those not
vaccinated at the beginning of the age interval, was esti-
mated for each interval. At any given age, cumulative
vaccination coverage was calculated as 1 − S(age). Finally,
we applied a Cox proportional hazard regression with
shared frailty to account for variation within clusters to
examine factors associated with vaccination delays (two
separate models for DTP3 and MCV vaccinations). A
frailty is a latent random effect that enters multiplica-
tively on the hazard function [23]. The models were ad-
justed for the following variables: child’s gender, place of
residence, birth order, mother’s age, education, house-
hold’s wealth index, and region. In addition, the models
were adjusted for child’s year of birth to control for un-
measured birth cohort effects. The analysis was done
with the statistical programs SPSS for Windows, version
19 (IBM Corporation, Armonk, NY, United States) and
STATA for Windows, version 12 (StataCorp LP, Texas,
United States).
Ethical approval
The analysis of this study was based on existing survey
data collected by the DHS (The DHS Programme,
www.dhsprogram.com). All surveys included in the ana-
lysis were approved by the Institutional Review Board ofICF International in Calverton, MD, USA. Study partici-
pants provided informed consent before participation.
Survey data were provided by ICF International, Inc.
Results
Characteristics of the samples
In both countries, the proportion of the study popula-
tion born in a health care facility and with higher mater-
nal education level increased from 2000 to 2010 (Armenia)
and from 1997 to 2012 (Kyrgyzstan), respectively (Table 2).
The proportion of available vaccination cards in Armenia
remained between 91 and 93 % without a clear trend, while
it increased in Kyrgyzstan from 76 % to 89 %.
Up-to-date (UTD) vaccination coverage
UTD vaccination coverage for all three doses of the
DTP vaccine increased significantly in Armenia from
92 % in 2000 to 96 % in 2010 (Fig. 1; p for trend <0.0001
[DTP1], <0.0001 [DTP2], and 0.001 [DTP3]). In
Kyrgyzstan, DTP coverage was 96 % and 97 % in 1997 and
2012, respectively (Fig. 1; p for trend 0.76 [DTP1], 0.52
[DTP2], and 0.41 [DTP3]). In both countries, the UTD
vaccination coverage with MCV was less than 90 % in the
older surveys and increased over the survey years, reaching
the mark of 95 % (p for trend <0.0001 in both countries).
Changes over time in correctly timed vaccination
In both countries, the proportion of correctly timed vac-
cinations increased considerably over time for all exam-
ined vaccinations (Table 3). The largest increase in
correctly timed vaccinations was observed for MCV in
Armenia, increasing from 39 % in the survey 2000 to
62 % in 2012, amounting to an increase of 59 %. In
Armenia, 46 %, 51 % and 66 % of children received
DTP1 before the age of 3 months in 2000, 2005 and
2012, respectively (Table 3, Fig. 2). A similar trend was
observed in Kyrgyzstan: 75 % and 87 % of children re-
ceived DTP1 before the age of 2 months in 1997 and
2012, respectively. The median time of delay (weeks) de-
creased in both countries (Table 3). The proportion of
children with correctly timed vaccinations was higher in
Kyrgyzstan than in Armenia (Fig. 2).
Factors associated with time to start of vaccinations
In Armenia, living in urban areas was associated with
delays with both DTP3 and MCV vaccinations
(Table 4, second and third columns). Additionally, ma-
ternal age was associated with correctly timed DTP3 and
MCV vaccinations, and children of younger mothers
were more likely to have correctly timed vaccinations.
Regional differences in timely vaccinations were found
in both countries. In Armenia, DTP3 and MCV vaccina-
tions were more likely to be delayed in the Armavir and
Syunik regions than in the capital city, Yerevan. In












Male 56.4 53.6 52.6 51.1 51.4
Female 43.6 46.4 47.4 48.9 48.9
Childhood place of residence
Urban 43.9 67.0 65.5 25.4 25.4
Rural 56.1 33.0 34.5 74.6 74.6
Child’s place of birth
Delivery at home 8.5 1.9 0.2 3.2 0.4
Delivery in health care facility 91.5 98.1 99.8 96.8 99.6
Mother’s education
Primary 0.2 0.3 5.4 0.2 0.3
Secondary 84.5 78.3 37.7 86.0 55.9
Higher 15.4 21.4 56.9 13.8 44.1
Vaccination cards available
No 7.6 8.5 6.9 24.4 11.3
Yes 92.4 91.5 93.1 75.6 88.7
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cination was more likely to be delayed in Bishkek, the
capital city, compared to other regions; MCV was de-
layed in the capital Bishkek compared to the regions of
Issyk-Kul, Djalal-Abad, Talas and Osh.
Discussion
To our knowledge, this is the first paper to investigate
trends in vaccination coverage and correct timing of
vaccinations in the former Soviet Republics of Armenia
and Kyrgyzstan. Based on survey data from 2000, 2005
and 2010 in Armenia and from 1997 and 2012 inFig. 1 Changes in up-to-date vaccination coverage over survey years*. *Up
60 months for the DTP vaccines and between 18 and 60 months for a mea
immunization records and maternal reportsKyrgyzstan, we observed that vaccination coverage and
correct timing improved over time in both countries.
The improvement was more prominent in Armenia
when comparing earlier surveys in both countries. To
start with, Kyrgyzstan had a better and relatively higher
vaccination coverage and better timing than Armenia. A
59 % increase in correct vaccination timing in Armenia
was reported in MCV over the last decade in Armenia.
Furthermore, available incidence data on measles, diph-
theria and tetanus from Armenia and Kyrgyzstan cor-
roborate our findings. No cases of diphtheria have been
reported in the past few years in both countries [24].-to-date vaccination coverage among children aged between 12 and
sles-containing vaccine. Information on coverage is based on
Table 3 Estimates of correctly timed vaccination according to the recommended ages at vaccination (%) and median delays (weeks)

















Survey 2000 46 6.3 29 10.7 22 16.4 39 8.7
Survey 2005 51 5.3 33 10.0 22 17.4 48 5.7
Survey 2010 66 3.0 50 6.1 40 9.6 62 3.3
Kyrgyzstan
Survey 1997 75 2.0 59 4.6 46 7.4 67 2.3
Survey 2012 87 1.1 73 3.0 59 5.6 73 1.9
aVaccination was considered to be timed correctly if administered within 4 weeks after the recommended age specified in the national immunisation schedule
Schweitzer et al. BMC Public Health  (2015) 15:798 Page 5 of 9The incidence of measles has dropped substantially in
Kyrgyzstan, from 21 per 100,000 in 1997 to 0 per
100,000 in 2012 [24]. Similarly, in Armenia, the inci-
dence of measles has dropped from 71 per 100,000 in
2005 to 0 per 100,000 in 2012. The last measles outbreak
reported in either country was in Kyrgyzstan in 2011.
These changes could well be accounted for by the im-
provement in vaccination coverage and timing. Based on
the aforementioned data and our analysis one could con-
clude that there has been a reduction in vaccine-
preventable diseases in both countries.
This evolution could in part be accounted for by an in-
creased focus and prioritization of the elimination of
vaccine-preventable diseases in these two countries. The
elimination of measles and rubella remains a publicA B
E F
Age in months Age in months
Age in months Age in months
Fig. 2 Cumulative vaccination coverage (inverse Kaplan–Meier estimates). a
g. DTP3 and h. MCV in Kyrgyzstan. The vertical reference line indicates age
respective countrieshealth priority in Armenia and Kyrgyzstan. The World
Health Organization (WHO) together with other inter-
national organizations such as the United Nations
Children’s Fund (UNICEF) implemented a global strat-
egy for elimination of measles and rubella, and both
countries are also a party to this strategy. In particular,
elimination of measles and rubella is part of the public
health strategy of Armenia [25]. For measles elimination,
achieving 95 % vaccination coverage would be an im-
portant step [26]. According to Lernout et al., adherence
to age recommendations is harder to achieve for DTP
than for measles [1]. This can be due to the stricter vac-
cination schedule for this vaccine, i.e. frequency of doses,
and is reflected in the lower proportions of correctly
timed vaccinations reported for consecutive doses ofC D
G H
Age in months Age in months
Age in months Age in months
. DTP1; b. DTP2; c. DTP3 and d. MCV in Armenia. e. DTP1; f. DTP2,
at vaccination recommended by national vaccination schedules in the
Table 4 Factors associated with time to start vaccinations (hazard ratios and 95 % confidence intervals from multivariable Cox
proportional hazard regression with shared frailty)a
Armenia, 2010 Kyrgyzstan, 2012
DTP3 MCV DTP3 MCV
Gender HR (95 % CI) HR (95 % CI) HR (95 % CI) HR (95 % CI)
Male vs. female 0.89 (0.78–1.02) 0.94 (0.82–1.08) 1.03 (0.95–1.10) 0.94 (0.87–1.02)
Childhood place of residence
Urban vs. rural 0.73 (0.57–0.92) 0.83 (0.67–1.03) 1.01 (0.82–1.25) 1.03 (0.85–1.23)
Birth order
1 vs. 3+ 0.63 (0.40–1.01) 0.97 (0.60–1.55) 1.01 (0.87–1.17) 1.02 (0.87–1.20)
2 vs. 3+ 0.61 (0.39–0.96) 0.84 (0.52–1.34) 0.96 (0.84–1.11) 1.00 (0.86–1.15)
3 vs. 3+ 0.55 (0.34–0.89) 0.80 (0.50–1.29) 1.04 (0.92–1.18) 1.10 (0.96–1.26)
Mother’s age
15–19 vs. 45–49 6.14 (1.76–21.42) 3.42 (0.89–13.17) 1.19 (0.69–2.04) 1.04 (0.51–2.09)
20–24 vs. 45–49 5.39 (1.73–16.83) 2.51 (0.80–7.82) 0.95 (0.65–1.39) 1.10 (0.75–1.61)
25–29 vs. 45–49 5.24 (1.70–16.19) 2.76 (0.90–8.54) 0.91 (0.63–1.31) 1.13 (0.78–1.62)
30–34 vs. 45–49 4.77 (1.54–14.73) 2.47 (0.80–7.64) 0.89 (0.62–1.28) 1.12 (0.78–1.60)
35–39 vs. 45–49 4.52 (1.44–14.17) 2.31 (0.74–7.23) 0.92 (0.64–1.33) 1.11 (0.77–1.59)
40–44 vs. 45–49 4.93 (1.46–16.75) 2.26 (0.67–7.60) 1.00 (0.68–1.47) 1.23 (0.84–1.79)
Mother’s education
Secondary vs. higher 0.95 (0.82–1.10) 0.91 (0.78–1.07) 0.95 (0.88–1.03) 1.01 (0.92–1.10)
Wealth index
Poorest vs. richest 0.92 (0.65–1.30) 0.97 (0.69–1.35) 1.14 (0.89–1.46) 0.89 (0.69–1.13)
Poor vs. richest 1.08 (0.81–1.45) 1.01 (0.76–1.34) 1.15 (0.90–1.47) 0.85 (0.66–1.09)
Middle vs. richest 0.96 (0.73–1.26) 0.88 (0.68–1.14) 1.15 (0.90–1.47) 0.91 (0.71–1.16)
Rich vs. richest 1.03 (0.80–1.33) 0.95 (0.74–1.21) 1.13 (0.92–1.40) 0.92 (0.75–1.14)
Region
Aragatsotn vs. Yerevan (capital) 1.00 (0.67–1.49) 0.98 (0.69–1.40) - -
Ararat vs. Yerevan (capital) 0.84 (0.56–1.27) 0.85 (0.59–1.21) - -
Armavir vs. Yerevan (capital) 0.60 (0.40–0.91) 0.71 (0.49–1.02) - -
Gegharkunik vs. Yerevan (capital) 1.05 (0.72–1.54) 0.74 (0.53–1.04) - -
Lori vs. Yerevan (capital) 0.81 (0.52–1.24) 0.89 (0.62–1.29) - -
Kotayk vs. Yerevan (capital) 0.87 (0.60–1.28) 0.86 (0.62–1.20) - -
Shirak vs. Yerevan (capital) 1.31 (0.90–1.91) 1.23 (0.89–1.72) - -
Syunik vs. Yerevan (capital) 0.39 (0.26–0.60) 0.38 (0.26–0.55) - -
VayotsDzor vs. Yerevan (capital) 0.77 (0.51–1.16) 0.77 (0.53–1.10) - -
Tavush vs. Yerevan (capital) 0.86 (0.59–1.26) 0.72 (0.52–1.01) - -
Issyk-Kul vs. Bishkek (capital) - - 2.93 (2.10–4.10) 1.34 (1.01–1.79)
Djalal-Abad vs. Bishkek (capital) - - 4.03 (2.89–5.64) 1.76 (1.33–3.32)
Naryn vs. Bishkek (capital) - - 1.96 (1.38–2.77) 1.21 (0.90–1.62)
Batken vs. Bishkek (capital) - - 1.94 (1.39–2.71) 0.94 (0.70–1.25)
Osh Oblast vs. Bishkek (capital) - - 1.59 (1.13–2.23) 1.24 (0.93–1.65)
Talas vs. Bishkek (capital) - - 2.49 (1.78–3.50) 1.53 (1.15–2.04)
Chui vs. Bishkek (capital) - - 2.55 (1.79–3.62) 1.10 (0.82–1.48)
Osh City vs. Bishkek (capital) - - 2.73 (2.00–3.71) 1.57 (1.20–2.05)
HR hazard ratio, CI confidence intervals
aAdjusted for child’s year of birth and other variables listed in the table
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proved timing of consecutive DTP doses was observed
over time in both countries. The results of our analysis are
encouraging as they clearly suggest that both countries have
achieved the recommended levels (95 % for MCV) of
coverage for the elimination of infections such as measles.
Although our results suggest that progress has been made,
additional efforts are needed. We observed that the up-to-
date coverage for DTP2 and DTP3 was still quite low in
both countries. This has important public health implica-
tions since transmission is likely to continue to pose risks
of outbreaks in unvaccinated or incompletely vaccinated
communities. This was evident in the diphtheria outbreak
reported in the 1990s in the republics of the former Soviet
Union [17, 18]. Maintaining high vaccination coverage is
hence essential to prevent outbreaks and sustain disease
elimination.
In Armenia, outpatient care is provided by urban poly-
clinics, rural health centers/ambulatories, and feldsher-
accoucher posts (physician’s assistant/midwife) [20]. In
Kyrgyzstan, primary health care, which includes child-
hood vaccination, is provided through feldsher-accoucher
posts, groups of family doctors, family medicine centers,
and general practice centers [21]. These providers focus
primarily on disease prevention, vaccination, antenatal
care services, etc. [21]. Sufficient supplies of vaccine at
the health clinics and appropriate health care provider
reminder and recall systems are essential for efficient
vaccine delivery [27].
Vaccination timing, meaning the receipt of all scheduled
vaccinations in an age-appropriate fashion, is critical for re-
ducing infant morbidity and mortality globally [28]. The lit-
erature suggests that there are substantial differences in
vaccination between urban and rural areas [29, 30], with
poorer vaccination coverage and timing in rural areas as
compared to urban areas. In Armenia, however, the reverse
was found. This could be ascribed to increased rural-to-
urban migration which has been described in low- and
middle-income countries with large numbers of impover-
ished families living in slums [31]. Data from two surveys,
one conducted in the year 2000 and another in 2005 in
Armenia, indicate that there has been a recent increase in
internal migration in the country [32]. In the capital of
Armenia (Yerevan), in the year 2000 21 % of the residents
hailed from the countryside, whereas 35 % did in 2005 [32].
This has primarily been due to economic reasons [32].
Additionally, an increase in the proportion of women mi-
grating to Yerevan has been reported with an increase in
the number of families with non-co-resident men. These
individuals might have poor access to healthcare [33, 34].
This pattern of internal migration and associated poor ac-
cess to healthcare are a likely explanation of the lower tim-
ing of vaccination in urban Armenia, observed in our
analysis. Similarly, in Kyrgyzstan, internal migrationparticularly to the capital city Bishkek, resulting in an in-
creasing proportion of the urban poor, might account for
the lower timing of vaccination in Bishkek versus other re-
gions [35].
Mothers can be instrumental in gaining access to vac-
cination services for their children [36]. Previous studies
have shown that maternal socio-demographic factors
such as age and educational status are associated with
correctly timed vaccinations [36, 37]. Improved vaccin-
ation rates have been reported with higher maternal
education levels [30], which is in line with our findings.
In our study, the likelihood of timely vaccination was
higher among children with younger mothers. This con-
curs with the findings of Luman et al. [4, 36]. A possible
explanation might be a higher awareness of vaccination
among young mothers, since vaccination awareness has
been found to be associated with vaccination coverage
and completeness [38]. Additionally, older mothers are
more likely to have more children, and caring for mul-
tiple children can in itself be a barrier to vaccination
[36]. Luman et al. reported that mothers with two or
three children were 20 % less likely and those with four
or more children were 40 % less likely to have vacci-
nated children than those with only one child [36].
Other studies, however, report that the likelihood of
properly timed vaccination increases with maternal age,
which has been attributed to experience accumulated
over time on the importance of vaccination and also on
fatalities that might have occurred to children who were
not vaccinated [37, 39, 40].
We found a higher vaccination coverage reported for
measles, as per basic health statistics for the Member
States of the WHO European Region [24], as compared
to our estimates for both countries. In this case, the
higher coverage might be partly attributable to the fact
that children with contraindications to immunizations
are excluded from official estimates of vaccination cover-
age in these countries [18]. This underscores the import-
ance of having independent, additional sources of data
such as the DHS to assess vaccination coverage and
other health parameters.
Limitations and strength of the study
Our findings are based on DHS survey data. Hence, our
results depend on the quality of DHS data. DHS is the
largest program for the collection of quantitative data on
population and health from households in low- and
middle-income countries and is considered to be one of
the best sources of population-based information on
health and health service utilization [40]. As far as the
representativeness of the data is concerned, consistent
sampling methods and questionnaires are used in DHS
surveys in every country. We did not compare the two
countries since the survey years and the observation
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were not strictly comparable. We limited our analysis
to vaccines for which data were available to assess
changes in correctly timed vaccination. We were un-
able to assess timing for all nationally recommended
vaccines.
Vaccination data in our analysis were obtained mostly
from child health cards available at local health care fa-
cilities and by information recalled by the mother in the
event that the mother did not have a child health card
or an immunization was not recorded on the card.
Hence, the possibility of recall bias and incompleteness
of data bears mention. We applied the 1 minus the
Kaplan-Meier function to estimate the proportion vacci-
nated by age, which is consistent with previous studies
[3, 9, 29, 37]. This method enables visualizing vaccination
uptake over time (or age) and provides estimates of the
proportion vaccinated at a given age. This in turn makes it
possible to monitor vaccination program effectiveness in
terms of achieving target coverage rates [42]. However, this
method consistently gives higher results than conventional
methods due to censoring, as this method reduces the
population at risk at the time point when censoring occurs.
As the number of individuals under observation decreases
with time, the right part of the curve becomes unstable
and, accordingly, warrants careful interpretation [43].
Conclusions
Our analysis suggests that vaccination coverage and cor-
rect timing in Armenia and Kyrgyzstan have improved
over time. As a consequence of these developments, a
reduction in vaccine-preventable diseases in both coun-
tries has likely occurred. As we near the approaching
2015 Millennium Development Goals deadline, these re-
sults are promising. However, socio-demographic and
regional inequalities in vaccination timing persist.
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